- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 182 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 146 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- April 2024
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2024
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 101 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- November 2020
- 141 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- August 2019
- 325 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- December 2023
- 114 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2024
- 170 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP

The Active Implantable Medical Device (AIMD) market is a subset of the medical device industry that focuses on the development and production of medical devices that are implanted into the body. These devices are designed to monitor, diagnose, and treat a variety of medical conditions. AIMDs are typically powered by batteries and are designed to be implanted for long-term use. Examples of AIMDs include pacemakers, implantable cardioverter defibrillators, neurostimulators, and drug delivery systems.
AIMDs are regulated by the Food and Drug Administration (FDA) and must meet stringent safety and efficacy standards. The market is highly competitive, with a number of large companies competing for market share.
Some of the major players in the AIMD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more